BitMEX
BitMEX Study Reveals Superior Performance of Perpetual Swap Listings, with an Average Price Gain of 62.55%, Outperforming Competitors
BitMEX Study Reveals Superior Performance of Perpetual Swap Listings, with an Average Price Gain of 62.55%, Outperforming Competitors
MAHE, Seychelles, April 07, 2025 (GLOBE NEWSWIRE) -- BitMEX, the OG crypto derivatives exchange, today shared a comprehensive analysis of perpetual swap listings across major centralised exchanges, shedding light on the behaviour of newly listed perpetual swap contracts – and whether they see their price peak on the first day of listing. The study, which compares listings on BitMEX, Binance, Bybit, and OKX from the beginning of 2025 to March 2025, highlights significant exchange-specific variations in price performance.
Key findings from the the study include:
- BitMEX Outperformance: BitMEX emerged as a standout exchange with the highest number of perpetual swap listings, with an average gain of 62.55% among listings that appreciated after the first day. Notably, 58.33% of its listings continued to appreciate post-listing day.
- Exchange Variability: The data shows that only 41.67% of BitMEX listings reached their all-time high (ATH) on the first day, contrasting with 70.83% on OKX and 50% on Binance. This indicates that the "first day peak" theory is not universally applicable across exchanges.
- Price Peak Timing: Most tokens that appreciate post-listing reach their maximum price within the first week, with BitMEX listings taking a median of six days to peak.
"Our analysis highlights BitMEX's unique ability to identify and support promising token projects, offering traders a platform where they can capitalise on sustained price appreciation. This is a testament to our rigorous listing process and market structure, which we believe provides a competitive edge for both traders and listed assets," said Stephan Lutz, CEO of BitMEX.
The study underscores the importance of exchange-specific dynamics in helping traders profit from trading perpetual swap listings. By leveraging these insights, traders can develop more effective strategies for navigating the evolving landscape of new perpetual swap listings. With its superior listing performance and sustained price appreciation, BitMEX remains a preferred platform for both traders and projects seeking to maximise their potential in the cryptocurrency derivatives market.
More details about the study can be found here.
About BitMEX
BitMEX is the OG crypto derivatives exchange, providing professional crypto traders with a platform that caters to their needs through low latency, deep crypto native liquidity and unmatched reliability.
Since its founding, no cryptocurrency has been lost through intrusion or hacking, allowing BitMEX users to trade safely in the knowledge that their funds are secure. So too that they have access to the products and tools they require to be profitable.
BitMEX was also one of the first exchanges to publish their on-chain Proof of Reserves and Proof of Liabilities data. The exchange continues to publish this data twice a week – proving assurance that they safely store and segregate the funds they are entrusted with.
For more information on BitMEX, please visit the BitMEX Blog or www.bitmex.com, and follow Telegram, Twitter, Discord, and its online communities. For further inquiries, please contact press@bitmex.com.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8e080d1e-14ac-4d23-99ee-8330752f93f1

Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
MoonLake Immunotherapeutics AG25.4.2025 22:05:00 CEST | Press release
MoonLake Immunotherapeutics to host a Capital Markets Day on Tuesday, April 29
T-knife Therapeutics25.4.2025 19:00:00 CEST | Press release
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
Zymeworks Inc.25.4.2025 19:00:00 CEST | Press release
Zymeworks Presents New Data from Multiple Development Programs at 2025 AACR Annual Meeting
Sequana Medical NV25.4.2025 18:00:00 CEST | Press release
Press release: Transparency Notification from Shareholders
Sanoma Corp25.4.2025 17:30:00 CEST | Press release
SANOMA CORPORATION: ACQUISITION OF OWN SHARES 25 April 2025
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom